Serum Institute of India manufactured vaccine doses for a trial involving the University of Oxford.
2 reports, 1 independent
Updated Jul 24
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Serum Institute of India manufactured vaccine doses for a trial involving the University of Oxford.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
University of Oxford
collegiate research university in Oxford, England
- Mathews Mtumbuka's career journey includes studying engineering at MUBAS, working for Airtel in Malawi, and later gaining experience with Shell Oil in Scotland before pursuing a PhD at the University of Oxford.
- A study focused on high blood pressure in England was conducted using data from the Our Future Health programme.
-
Serum Institute of India
Indian biotechnological company, vaccine manufacturer
Nothing else this week.